Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release cisplatin implant in inoperable esophageal cancer
CTR20132940Phase 2Completed
- Sponsor
- Anhui Zhongren Technology
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in esophageal cancer, sponsored by Anhui Zhongren Technology. Started Mar 2014; status: completed.
02
Drugs
cisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on CTR20132940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132940.